← Leaderboards
Sarah Martinez Roth
Georgetown University
$100,677
Attributed
$100,677
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $35.5K · FY2018–20$50K$37.5K$25K$12.5K$0
'18
'19
'20
Funding mix
By agency
NIH$100,677 · 1
By mechanism
F31$100,677 · 1
Top collaborators
No co-investigators on record.
Most similar at Georgetown University
Same institution · by research overlap
- Alejandro V Villagra$1,948,655
- Naiyer A Rizvi$2,808,393
- Duncan John Wardrop$3,076,392
- Cyril Barinka$792,791
- Anton Wellstein$12,396,274
Others in their field
Other Emerging Leaders on “Dna Methylation”
- Sonia Minikel Vallabh · Broad Institute, Inc.$14,507,691
- Chongyuan Luo · University Of California Los Angeles$9,805,856
- Leonard Freedman · Leidos Biomedical Research, Inc.$9,392,562
- Michael-Christopher Keogh · Epicypher, Inc.$8,161,366
- Carl Rhodes · University Of Washington$8,047,567
- Himisha Beltran · Dana-Farber Cancer Inst$7,515,798
Research focus
Dna MethylationDrug ResistanceAffectDna AnalysisAntibodiesAdverse EventAnti-Pd-1Autoimmune ProcessAftercareAdverse EffectsBlood SpecimenBody SystemBraf GeneCancer PatientCancer TherapyCell Free DnaCellsCell TypeCheckpoint InhibitionBaseBisulfite SequencingData AnalysesDetectionDrug Targeting
Grant awards (3)
Molecular indicators of treatment responses and adverse events in melanoma$32,820
F31 · FY2020 · CA · contact PI
Molecular indicators of treatment responses and adverse events in melanoma$32,316
F31 · FY2019 · CA · contact PI
Molecular indicators of treatment responses and adverse events in melanoma$35,541
F31 · FY2018 · CA · contact PI